The Expanding and Promoting Expertise in Rare Treatments Act (S. 2281) was introduced in the 112th Congress, which has adjourned.

It has not yet been reintroduced.

You can increase the chances that the bill is revived in the new Congress by showing support for reintroduction.

Want to be notified when this bill is reintroduced?

View S. 2281 (112th) report

What’s your position on
The Expanding and Promoting Expertise in Rare Treatments Act

S. 2281: Expanding and Promoting Expertise in Rare Treatments Act of 2012

Summary: A bill to amend the Federal Food, Drug, and Cosmetic Act to strengthen the ability of the Food and Drug Administration to seek advice from external experts regarding rare diseases, the burden of rare diseases, and the unmet medical needs of individuals with rare diseases. (More Info)

The Expanding and Promoting Expertise in Rare Treatments Act (S. 2281) was introduced in the 112th Congress, which has adjourned. It has not yet been reintroduced.

What POPVOX Users Say

POPVOX Nation:
0% Support
100% Oppose
(2 users)

View Report & Comments

0 users
2 users
order determined by social media popularity

Endorsing Organizations

No organization has endorsed this bill yet on POPVOX.